Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127551432 | 12755143 | 2 | F | 20160927 | 20160916 | 20160930 | EXP | JP-JNJFOC-20160903091 | JANSSEN | NAKAMURA M. A CASE OF RHEUMATOID ARTHRITIS WHO HAD RECURRENCE OF IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE DURING TREATMENT WITH ABATACEPT. 52ND MEETING OF KYUSHU COLLEGE OF RHEUMATOLOGY 2016:74. | 68.00 | YR | E | M | Y | 0.00000 | 20160930 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127551432 | 12755143 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | N | 0 | LYOPHILIZED POWDER | ||||||||
| 127551432 | 12755143 | 2 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | N | 103772 | LYOPHILIZED POWDER | ||||||||
| 127551432 | 12755143 | 3 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
| 127551432 | 12755143 | 4 | SS | ABATACEPT | ABATACEPT | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127551432 | 12755143 | 1 | Rheumatoid arthritis |
| 127551432 | 12755143 | 2 | Rheumatoid arthritis |
| 127551432 | 12755143 | 3 | Rheumatoid arthritis |
| 127551432 | 12755143 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127551432 | 12755143 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127551432 | 12755143 | Lymphoproliferative disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |